Stay updated on FB825 Safety & Efficacy in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the FB825 Safety & Efficacy in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FB825 Safety & Efficacy in Atopic Dermatitis Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The record now displays details for the completed Phase 2 FB825 atopic dermatitis study, including eligibility criteria, treatment plan, outcome measures, locations, and study dates, instead of an access-denied error.
    Difference
    44%
    Check dated 2026-11-09T14:43:54.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer displays a newer ClinicalTrials.gov site revision, while the study record still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T16:22:23.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A banner announces that NIH is transitioning from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T15:45:15.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer site revision changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-19T15:45:50.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-12T15:40:53.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error, blocking access to the study record content. This appears to be an access/configuration issue rather than a substantive content update.
    Difference
    18%
    Check dated 2026-09-21T21:53:33.000Z thumbnail image

Stay in the know with updates to FB825 Safety & Efficacy in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FB825 Safety & Efficacy in Atopic Dermatitis Clinical Trial page.